Skip to main content
SAMJIN PHARMACEUTICAL CO.,LTD logo

SAMJIN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 005500 ISIN · KR7005500004 KO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2023-11-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 005500

About SAMJIN PHARMACEUTICAL CO.,LTD

https://www.samjinpharm.co.kr/

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details a change in shareholding by a major shareholder (Hana Pharm Co., Ltd.) in Samjin Pharm Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels and insider/major shareholder positions.
2023-11-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and the purpose of holding (management influence) for a major shareholder and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-10-30 Korean
신탁계약해지결과보고서
Regulatory Filings Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by Samjin Pharmaceutical Co., Ltd. with the Financial Supervisory Service (FSS). It details the termination of a treasury stock trust contract and the subsequent transfer of shares to the company's own account. This type of filing, which reports on the status of treasury shares following the termination of a trust, falls under the category of 'Transaction in Own Shares' (POS) as it relates to the company's management of its own equity through share buyback/trust mechanisms.
2023-09-25 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Exchange regarding the termination of a treasury stock trust agreement (자기주식취득 신탁계약 해지 결정). This involves the company's management of its own shares, specifically the termination of a trust contract and the subsequent return of shares to the company's account. This falls under the category of 'Transaction in Own Shares' (POS), which covers share buybacks, trust contract terminations, and related treasury share movements.
2023-09-22 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status via Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Samjin Pharmaceutical Co., Ltd. to the Financial Supervisory Service (FSS). It details the company's purchase of its own shares through a trust contract with Mirae Asset Securities. This type of filing, which reports the company's buyback activity, falls under the 'Transaction in Own Shares' category.
2023-09-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share ownership, special relationships, and changes in collateral/contracts for major shareholders of Samjin Pharmaceutical Co., Ltd. This type of filing is a standard regulatory disclosure regarding significant ownership thresholds and is classified as a Major Shareholding Notification.
2023-09-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.